Abstract
Public discourse on medicine provision predominantly focuses on overall expenditure. However, current literature suggests measurement of alternative indicators can provide a method to benchmark or ameliorate medicine provision. Previous research has investigated the viability of using health-related outcome metrics, such as the number of patients treated, quality-adjusted life-year gain and life-year gain, to provide macro-level estimates on medicines' societal contributions. This editorial provides an overview of the evolving healthcare landscape surrounding medicine usage estimation and valuation in Ireland and offers recommendations on how improved methods of measuring health-related outcomes may help ameliorate efficiencies and the sustainability of a healthcare system.
| Original language | English |
|---|---|
| Article number | 202042 |
| Journal | Drugs in Context |
| Volume | 9 |
| DOIs | |
| Publication status | Published - 22 May 2020 |
Keywords
- Drug utilisation
- Health economics
- Life years gained
- Number of patients treated
- Pharmacoeconomics
- Quality-adjusted life years
Fingerprint
Dive into the research topics of 'Overcoming hurdles: Measurement of health-related outcomes associated with national level medicines usage in Ireland'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver